FrancophonIA/ELRC3.0 huggingface dataset:
English: A precise frequency estimation is not possible as the side effect did not occur in a clinical trial database of 1,395 patients with Restless Legs Syndrome treated with pramipexole
Croatian: Precizna procjena učestalosti nije moguća, s obzirom na to da se nuspojava nije pojavila u bazi podataka kliničkog ispitivanja u 1395 bolesnika sa sindromom nemirnih nogu liječenih pramipeksolom.
English: How to take MIRAPEXIN
Croatian: Kako uzimati MIRAPEXIN
English: Co-administration of antipsychotic medicinal products with pramipexole should be avoided (see section 4.5).
Croatian: Treba izbjegavati istodobnu primjenu antipsihotičnih lijekova i pramipeksola (vidjeti dio 4.5).
English: Take care if you are taking the following medicines: - cimetidine (to treat excess stomach acid and stomach ulcers) - amantadine (which can be used to treat Parkinson's disease) - mexiletine (to treat irregular heartbeats, a condition known as ventricular arrhythmia) - zidovudine (which can be used to treat the acquired immune deficiency syndrome (AIDS), a disease of the human immune system) - cisplatin (to treat various types of cancers) - quinine (which can be used for the prevention of painful night-time leg cramps and for the treatment of a type of malaria known as falciparum malaria (malignant malaria)) - procainamide (to treat irregular heart beat)
Croatian: Budite na oprezu ako uzimate sljedeće lijekove: - cimetidin (za liječenje prekomjernog stvaranja želučane kiseline i želučanih ulkusa) - amantadin (koji se primjenjuje u liječenju Parkinsonove bolesti) - meksiletin (za liječenje nepravilnih otkucaja srca, stanja koje se naziva ventrikularna aritmija) - zidovudin (koji se može primjenjivati u liječenju stečenog sindroma imunodeficijencije (SIDA),
English: Very common: - Dyskinesia (e.g. abnormal, uncontrolled movements of the limbs) - Sleepiness - Dizziness - Nausea (sickness)
Croatian: Vrlo često: - diskinezija (npr. abnormalni, nekontrolirani pokreti udova) - pospanost - omaglica - mučnina
English: In severe kidney disease, the usual starting dose is just 1 tablet MIRAPEXIN 0.088 mg a day.
Croatian: Kod teške bolesti bubrega, uobičajena početna doza je samo 1 tableta MIRAPEXIN 0,088 mg dnevno.
English: Each tablet contains 0.088 mg, 0.18 mg, 0.35 mg, or 0.7 mg pramipexole as 0.125 mg, 0.25 mg, 0.5 mg, or 1 mg pramipexole dihydrochloride monohydrate, respectively.
Croatian: Jedna tableta sadrži: 0,088 mg; 0,18 mg; 0,35 mg; ili 0,7 mg pramipeksola u obliku 0,125 mg; 0,25 mg; 0,5 mg; ili 1 mg pramipeksoldiklorid hidrata, po istom redoslijedu.
English: Each tablet contains 0.26 mg, 0.52 mg, 1.05 mg, 1.57 mg, 2.1 mg, 2.62 mg, or 3.15 mg pramipexole as 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, or 4.5 mg pramipexole dihydrochloride monohydrate, respectively.
Croatian: Jedna tableta sadrži 0,26 mg; 0,52 mg; 1,05 mg; 1,57 mg; 2,1 mg; 2,62 mg; ili 3,15 mg pramipeksola u obliku 0,375 mg; 0,75 mg; 1,5 mg; 2,25 mg; 3 mg; 3,75 mg; ili 4,5 mg pramipeksoldiklorid hidrata, po istom redoslijedu.
English: For the side effects marked with * a precise frequency estimation is not possible, since these side effects were not observed in clinical studies among 2,762 patients treated with pramipexole.
Croatian: Za nuspojave koje su označene sa * nije moguća precizna ocjena učestalosti, s obzirom da ove nuspojave nisu primijećene u kliničkim ispitivanjima na 2762 bolesnika liječenih pramipeksolom.
English: Ascending dose schedule of MIRAPEXIN prolonged-release tablets Week Daily dose (mg) Number of tablets One MIRAPEXIN 0.26 mg prolonged-release tablet.
Croatian: Režim doziranja MIRAPEXIN tableta s produljenim oslobađanjem Tjedan Dnevna doza (mg) Broj tableta Jedna MIRAPEXIN 0,26 mg tableta s produljenim oslobađanjem
English: MIRAPEXIN 0.7 mg tablets are white, of round shape, and flat.
Croatian: MIRAPEXIN 0,7 mg tablete su bijele, okruglog oblika, plosnate.
English: Reduction of the pramipexole dose should be considered when these medicinal products are administered concomitantly with MIRAPEXIN.
Croatian: Potrebno je razmotriti mogućnost sniženja doze pramipeksola u slučaju primjene navedenih lijekova u kombinaciji s MIRAPEXINOM.
English: Dose Schedule of MIRAPEXIN Titration Step Once Daily Evening Dose
Croatian: Raspored doziranja MIRAPEXINA Titracijski korak Večernja doza jedanput dnevno (mg baze)
English: Boehringer Ingelheim International GmbH D-55216 Ingelheim am Rhein Germany
Croatian: Boehringer Ingelheim International GmbH D-55216 Ingelheim am Rhein Njemačka
English: If you are switching from MIRAPEXIN (immediate release) tablets Your doctor will base your dose of MIRAPEXIN prolonged-release tablets on the dose of MIRAPEXIN (immediate release) tablets you were taking.
Croatian: Liječnik će započeti s dozom MIRAPEXIN tableta s produljenim oslobađanjem adekvatno Vašoj dozi MIRAPEXIN tableta (s trenutnim oslobađanjem) koju ste uzimali.
English: Boehringer Ingelheim Pharma GmbH & Co. KG D-55216 Ingelheim am Rhein Germany
Croatian: Boehringer Ingelheim Pharma GmbH & Co.KG D-55216 Ingelheim am Rhein Njemačka
English: 1 tablet MIRAPEXIN 0.35 mg and 1 tablet MIRAPEXIN 0.18 mg OR
Croatian: 1 tableta MIRAPEXIN 0,35 mg i 1 tableta MIRAPEXIN 0,18 mg ILI
English: A lower maintenance dose of one MIRAPEXIN 0.26 mg prolonged-release tablet a day is also possible.
Croatian: Također je moguća niža doza održavanja od jedne MIRAPEXIN 0,26 mg tablete s produljenim oslobađanjem dnevno.
English: 1 tablet MIRAPEXIN 0.7 mg and 1 tablet MIRAPEXIN 0.35 mg three times a day
Croatian: 1 tableta MIRAPEXIN 0,7 mg i 1 tableta MIRAPEXIN 0,35 mg tri puta dnevno
English: MIRAPEXIN 0.18 mg tablets and MIRAPEXIN 0.35 mg tablets are white, of oval shape, and flat.
Croatian: MIRAPEXIN 0,18 mg tablete i MIRAPEXIN 0,35 mg tablete su bijele, ovalnog oblika, plosnate.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23 February 1998
Croatian: DATUM PRVOG ODOBRENJA / DATUM OBNOVE ODOBRENJA
English: Common: - Changes in sleep pattern, such as sleeplessness (insomnia) and sleepiness - Tiredness (fatigue) - Headache - Abnormal dreams - Constipation - Dizziness - Vomiting (being sick)
Croatian: Često: - promjene u obrascu spavanja, kao što su nesanica i pospanost - umor - glavobolja - neobični snovi
English: If necessary, your doctor may increase your dose up to a maximum of 3.15 mg of pramipexole a day.
Croatian: Ako je potrebno, liječnik će povisiti dozu tableta do maksimalno 3,15 mg pramipeksola dnevno.
English: Uncommon: - Urge to behave in an unusual way* - Cardiac failure (heart problems which can cause shortness of breath or ankle swelling)* - Inappropriate antidiuretic hormone secretion* - Dyskinesia (e.g. abnormal, uncontrolled movements of the limbs) - Hyperkinesia (increased movements and inability to keep still)* - Paranoia (e.g. excessive fear for one's own well-being)* - Delusion* - Amnesia (memory disturbance)* - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Excessive daytime sleepiness and suddenly falling asleep - Weight increase - Hypotension (low blood pressure) - Excess of fluid, usually in the legs (peripheral oedema) - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Restlessness - Visual impairment - Weight loss including decreased appetite - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs)* - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Croatian: Manje često: - potreba za neuobičajenim ponašanjem* - zatajenje srca (problemi sa srcem koji mogu izazvati nedostatak zraka i otečenost gležnjeva)* - neodgovarajuće lučenje antidiuretskog hormona* - diskinezija (npr. abnormalni, nekontrolirani pokreti udova) - hiperkinezija (učestali pokreti i nesposobnost ostajanja u mirnom položaju)* - paranoja (npr. pretjeran strah za vlastitu dobrobit)* - zablude (deluzije)* - amnezija (poremećaj pamćenja)* - halucinacije (vidjeti, čuti ili osjećati stvari koje nisu prisutne) - smetenost - prekomjerna dnevna pospanost i iznenadno usnivanje - porast tjelesne težine - hipotenzija (niski krvni tlak) - prekomjerno nakupljanje tekućine, obično u nogama (periferni edem) - alergijske reakcije (npr. osip, svrbež, preosjetljivost) - nesvjestica - nemir - poremećaj vida - gubitak težine uključujući smanjeni apetit - zaduha (otežano disanje) - štucanje - upala pluća (infekcija pluća)* - Nemogućnost odupiranja nagonu, porivu ili iskušenju za vršenje radnji koje bi mogle naškoditi
English: MIRAPEXIN 0.26 mg prolonged-release tablets MIRAPEXIN 0.52 mg prolonged-release tablets MIRAPEXIN 1.05 mg prolonged-release tablets MIRAPEXIN 1.57 mg prolonged-release tablets MIRAPEXIN 2.1 mg prolonged-release tablets MIRAPEXIN 2.62 mg prolonged-release tablets MIRAPEXIN 3.15 mg prolonged-release tablets
Croatian: MIRAPEXIN 0,26 mg tablete s produljenim oslobađanjem MIRAPEXIN 0,52 mg tablete s produljenim oslobađanjem MIRAPEXIN 1,05 mg tablete s produljenim oslobađanjem MIRAPEXIN 1,57 mg tablete s produljenim oslobađanjem MIRAPEXIN 2,1 mg tablete s produljenim oslobađanjem MIRAPEXIN 2,62 mg tablete s produljenim oslobađanjem MIRAPEXIN 3,15 mg tablete s produljenim oslobađanjem pramipeksol
English: How to store MIRAPEXIN
Croatian: Kako čuvati MIRAPEXIN
English: In clinical studies and post-marketing experience cardiac failure has been reported in patients with pramipexole.
Croatian: U kliničkim studijama i tijekom razdoblja nakon izdavanja odobrenja za stavljanje gotovog lijeka u promet prijavljeno je zatajenje srca kod bolesnika na pramipeksolu.
English: two MIRAPEXIN 0.52 mg prolonged-release tablets, OR four MIRAPEXIN 0.26 mg prolonged-release tablets.
Croatian: ILI dvije MIRAPEXIN 0,52 mg tablete s produljenim oslobađanjem ILI četiri MIRAPEXIN 0,26 tablete s produljenim oslobađanjem.
English: However, it should be noted that the incidence of somnolence is increased at doses higher than 1.5 mg (of salt) per day (see section 4.8).
Croatian: Međutim, potrebno je napomenuti da se incidencija somnolencije povećava pri dozama višim od 1,5 mg (soli) dnevno (vidjeti dio 4.8).
English: Patients must be informed of this and advised to exercise caution while driving or operating machines during treatment with MIRAPEXIN.
Croatian: Tijekom liječenja MIRAPEXINOM bolesnici moraju biti informirani o tome, te ih se mora upozoriti na povećan oprez pri upravljanju motornim vozilima ili strojevima.
English: Take your MIRAPEXIN (immediate release) tablets as normal the day before you switch.
Croatian: Uzmite MIRAPEXIN tablete (s trenutnim oslobađanjem) po uobičajenom rasporedu dan prije prijelaza na drugu terapiju.
English: How to store MIRAPEXIN Contents of the pack and other information
Croatian: Kako MIRAPEXIN izgleda i sadržaj pakiranja
English: MIRAPEXIN 0.088 mg tablets MIRAPEXIN 0.18 mg tablets MIRAPEXIN 0.35 mg tablets MIRAPEXIN 0.7 mg tablets Pramipexole
Croatian: MIRAPEXIN 0,088 mg tablete MIRAPEXIN 0,18 mg tablete MIRAPEXIN 0,35 mg tablete MIRAPEXIN 0,7 mg tablete pramipeksol
English: MIRAPEXIN 0.088 mg tablets MIRAPEXIN 0.18 mg tablets MIRAPEXIN 0.35 mg tablets MIRAPEXIN 0.7 mg tablets
Croatian: MIRAPEXIN 0,088 mg tablete MIRAPEXIN 0,18 mg tablete MIRAPEXIN 0,35 mg tablete MIRAPEXIN 0,7 mg tablete
English: Tourette Disorder
Croatian: Touretteov sindrom
English: Common: - Urge to behave in an unusual way - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Tiredness (fatigue) - Sleeplessness (insomnia) - Excess of fluid, usually in the legs (peripheral oedema) - Headache - Hypotension (low blood pressure) - Abnormal dreams - Constipation - Visual impairment - Vomiting (being sick) - Weight loss including decreased appetite
Croatian: Često: - potreba za neuobičajenim ponašanjem - halucinacije (vidjeti, čuti ili osjećati stvari koje nisu prisutne) - smetenost - umor - nesanica - prekomjerna količina tekućine, obično u nogama (periferni edem) - glavobolja - hipotenzija (niski krvni tlak) - neuobičajeni snovi - zatvor - poremećaji vida - povraćanje - gubitak težine uključujući smanjen apetit
English: Uncommon (≥1/1,000 to
Croatian: Manje često (≥1/1000 i < 1/100)
English: This side effect has been observed in post-marketing experience.
Croatian: Ova je nuspojava primijećena u razdoblju nakon stavljanja lijeka u promet.
English: sweating or pain may occur (called dopamine agonist withdrawal syndrome or DAWS).
Croatian: tjeskoba, umor, znojenje ili bol (što se naziva sindromom ustezanja od agonista dopamina).
English: Uncommon: - Paranoia (e.g. excessive fear for one's own well-being) - Delusion - Excessive daytime sleepiness and suddenly falling asleep - Amnesia (memory disturbance) - Hyperkinesia (increased movements and inability to keep still) - Weight increase - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Cardiac failure (heart problems which can cause shortness of breath or ankle swelling)* - Inappropriate antidiuretic hormone secretion* - Restlessness - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs) - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Croatian: Manje često: - paranoja (npr. pretjeran strah za vlastitu dobrobit) - zablude (deluzije) - prekomjerna dnevna pospanost i iznenadno usnivanje - amnezija (poremećaj pamćenja) - hiperkinezija (učestali pokreti i nesposobnost ostajanja u mirnom položaju) - porast tjelesne težine - alergijske reakcije (npr. osip, svrbež, preosjetljivost) - nesvjestica - zatajenje srca (problemi sa srcem koji mogu izazvati nedostatak zraka ili otečenost gležnjeva)*
English: 1 tablet MIRAPEXIN 0.35 mg
Croatian: 1 tableta MIRAPEXIN 0,35 mg
English: Doses should be increased gradually from a starting dose of 0.26 mg of base (0.375 mg of salt) per day and then increased every 5-7 days.
Croatian: Dozu je potrebno postupno povisivati od početne doze 0,26 mg baze (0,375 mg soli) dnevno, svakih 5-7 dana.
English: MARKETING AUTHORISATION NUMBER(S) MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/013-015
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET MIRAPEXIN 0,26 mg tablete s produljenim oslobađanjem EU/1/97/051/013-015
English: MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-033
Croatian: MIRAPEXIN 2,62 mg tablete s produljenim oslobađanjem EU/1/97/051/031-033
English: MIRAPEXIN 0.26 mg prolonged-release tablets Each prolonged-release tablet contains 0.375 mg pramipexole dihydrochloride monohydrate equivalent to 0.26 mg pramipexole.
Croatian: MIRAPEXIN 0,26 mg tablete s produljenim oslobađanjem Jedna tableta s produljenim oslobađanjem sadrži 0,375 mg pramipeksoldiklorid hidrata, što odgovara 0,26 mg pramipeksola.
English: MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012
Croatian: MIRAPEXIN 0,35 mg tablete EU/1/97/051/011-012
English: Common: - Urge to behave in an unusual way - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Tiredness (fatigue) - Sleeplessness (insomnia) - Excess of fluid, usually in the legs (peripheral oedema) - Headache - Hypotension (low blood pressure) - Abnormal dreams - Constipation - Visual impairment
Croatian: Često: - potreba za neuobičajenim ponašanjem - halucinacije (vidjeti, čuti ili osjećati stvari koje nisu prisutne) - smetenost - umor - nesanica - prekomjerna količina tekućine, obično u nogama (periferni edem) - glavobolja
English: Doses should be increased gradually from a starting dose of 0.264 mg of base (0.375 mg of salt) per day and then increased every 5-7 days.
Croatian: Dozu je potrebno postupno povisivati od početne doze 0,264 mg baze (0,375 mg soli) dnevno, svakih 5-7 dana.
English: Very common may affect more than 1 in 10 people Common may affect up to 1 in 10 people
Croatian: Ocjena ovih nuspojava zasniva se na sljedećim učestalostima: Vrlo često mogu se javiti u više od 1 na 10 osoba
English: MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/016-018
Croatian: MIRAPEXIN 0,52 mg tablete s produljenim oslobađanjem EU/1/97/051/016-018
English: 1 tablet MIRAPEXIN 0.35 mg three times a day OR
Croatian: 1 tableta MIRAPEXINA 0,35 mg tri puta dnevno ILI
English: 1 tablet MIRAPEXIN 0.088 mg three times a day
Croatian: 1 tableta MIRAPEXIN 0,088 mg tri puta dnevno
English: MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002
Croatian: MIRAPEXIN 0,088 mg tablete EU/1/97/051/001-002
English: MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006
Croatian: MIRAPEXIN 0,7 mg tablete EU/1/97/051/005-006
English: - Vomiting (being sick) - Weight loss including decreased appetite
Croatian: - hipotenzija (niski krvni tlak) - neuobičajeni snovi - zatvor - poremećaji vida - povraćanje (osjećaj mučnine) - gubitak težine uključujući smanjen apetit
English: Restless Legs Syndrome, most common adverse reactions The most commonly (≥ 5%) reported adverse drug reactions in patients with Restless Legs Syndrome treated with pramipexole were nausea, headache, dizziness and fatigue.
Croatian: Najčešće (≥5%) prijavljene nuspojave u bolesnika sa sindromom nemirnih nogu, u liječenju pramipeksolom bile su mučnina, glavobolja, omaglica i umor.
English: 2 tablets MIRAPEXIN 0.18 mg three times a day
Croatian: 2 tablete MIRAPEXINA 0,18 mg tri puta dnevno
English: Nervous system disorders headache dizziness somnolance sudden onset of sleep syncope dyskinesia amnesia hyperkinesia
Croatian: Poremećaji živčanog sustava glavobolja omaglica somnolencija epizode iznenadnog usnivanja sinkopa diskinezija amnezija hiperkinezija
English: MIRAPEXIN 0.088 mg tablets
Croatian: MIRAPEXIN 0,088 mg tablete
English: MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004
Croatian: MIRAPEXIN 0,18 mg tablete EU/1/97/051/003-004
English: MIRAPEXIN 0.35 mg tablets
Croatian: MIRAPEXIN 0,35 mg tablete
English: 2 tablets MIRAPEXIN 0.088 mg three times a day
Croatian: 2 tablete MIRAPEXINA 0,088 mg tri puta dnevno
English: 1 tablet MIRAPEXIN 0.18 mg three times a day OR
Croatian: 1 tableta MIRAPEXINA 0,18 mg tri puta dnevno ILI
English: MIRAPEXIN 0.7 mg tablets
Croatian: MIRAPEXIN 0,7 mg tablete
English: Each prolonged-release tablet contains 1.5 mg pramipexole dihydrochloride monohydrate equivalent to 1.05 mg pramipexole.
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 1,5 mg pramipeksoldiklorid hidrata što odgovara 1,05 mg pramipeksola.
English: MIRAPEXIN 3.15 mg prolonged-release tablets EU/1/97/051/025-027
Croatian: MIRAPEXIN 3,15 mg tablete s produljenim oslobađanjem EU/1/97/051/025-027
English: 3 tablets MIRAPEXIN 0.18 mg
Croatian: 3 tablete MIRAPEXIN 0,18 mg
English: INFORMATION IN BRAILLE MIRAPEXIN 2.62 mg prolonged-release tablets
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 2,62 mg tablete s produljenim oslobađanjem
English: MIRAPEXIN 2.62 mg prolonged-release tablets
Croatian: MIRAPEXIN 2,62 mg tablete s produljenim oslobađanjem
English: MIRAPEXIN with food, drink and alcohol You should be cautious while drinking alcohol during treatment with MIRAPEXIN.
Croatian: MIRAPEXIN s hranom, pićem i alkoholom
English: MIRAPEXIN 0.18 mg tablets
Croatian: MIRAPEXIN 0,18 mg tablete
English: MIRAPEXIN 1.05 mg prolonged-release tablets EU/1/97/051/019-021
Croatian: MIRAPEXIN 1,05 mg tablete s produljenim oslobađanjem EU/1/97/051/019-021
English: MIRAPEXIN 1.57 mg prolonged-release tablets EU/1/97/051/028-030
Croatian: MIRAPEXIN 1,57 mg tablete s produljenim oslobađanjem EU/1/97/051/028-030
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 0.125 mg pramipexole dihydrochloride monohydrate equivalent to 0.088 mg pramipexole.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 0,125 mg pramipeksoldiklorid hidrata što odgovara 0,088 mg pramipeksola.
English: MIRAPEXIN 2.1 mg prolonged-release tablets EU/1/97/051/022-024
Croatian: MIRAPEXIN 2,1 mg tablete s produljenim oslobađanjem EU/1/97/051/022-024
English: Pramipexole should be tapered off at a rate of 0.54 mg of base (0.75 mg of salt) per day until the daily dose has been reduced to 0.54 mg of base (0.75 mg of salt).
Croatian: Stoga je potrebno postupno smanjivati dozu pramipeksola za 0,54 mg baze (0,75 mg soli) dnevno, sve dok se ukupna dnevna doza ne snizi na 0,54 mg baze (0,75 mg soli).
English: MIRAPEXIN 3.15 mg prolonged-release tablets
Croatian: MIRAPEXIN 3,15 mg tablete s produljenim oslobađanjem
English: INFORMATION IN BRAILLE MIRAPEXIN 0.35 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 0,35 mg
English: Each tablet contains 0.125 mg pramipexole dihydrochloride monohydrate equivalent to 0.088 mg pramipexole.
Croatian: Jedna tableta sadrži 0,125 mg pramipeksoldiklorid hidrata, što odgovara 0,088 mg pramipeksola.
English: 2 tablets MIRAPEXIN 0.18 mg
Croatian: 2 tablete MIRAPEXIN 0,18 mg
English: NAME OF THE MEDICINAL PRODUCT MIRAPEXIN 0.088 mg tablets Pramipexole
Croatian: NAZIV LIJEKA MIRAPEXIN 0,088 mg tablete pramipeksol
English: INFORMATION IN BRAILLE MIRAPEXIN 0.088 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 0,088 mg
English: MIRAPEXIN 0.52 mg prolonged-release tablets
Croatian: MIRAPEXIN 0,52 mg tablete s produljenim oslobađanjem
English: MIRAPEXIN 0.26 mg prolonged-release tablets
Croatian: MIRAPEXIN 0,26 mg tablete s produljenim oslobađanjem
English: INFORMATION IN BRAILLE MIRAPEXIN 0.26 mg prolonged-release tablets
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 0,26 mg tablete s produljenim oslobađanjem
English: INFORMATION IN BRAILLE MIRAPEXIN 1.57 mg prolonged-release tablets
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 1,57 mg tablete s produljenim oslobađanjem
English: MIRAPEXIN 1.57 mg prolonged-release tablets
Croatian: MIRAPEXIN 1,57 mg tablete s produljenim oslobađanjem
English: forward bending of the lower back (also called camptocormia) or sidewards bending of the back
Croatian: možete doživjeti savijanje glave i vrata prema naprijed (koje se naziva i antekolis), savijanje donjeg dijela leđa prema naprijed (što se naziva i kamptokormija) ili bočno savijanje leđa (što se naziva i pleurototonus ili Pisa sindrom).
English: MIRAPEXIN 1.05 mg prolonged-release tablets
Croatian: MIRAPEXIN 1,05 mg tablete s produljenim oslobađanjem
English: Each prolonged-release tablet contains 3.75 mg pramipexole dihydrochloride monohydrate equivalent to 2.62 mg pramipexole.
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 3,75 mg pramipeksoldiklorid hidrata što odgovara 2,62 mg pramipeksola.
English: INFORMATION IN BRAILLE MIRAPEXIN 3.15 mg prolonged-release tablets
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 3,15 mg tablete s produljenim oslobađanjem
English: INFORMATION IN BRAILLE MIRAPEXIN 0.52 mg prolonged-release tablets
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 0,52 mg tablete s produljenim oslobađanjem
English: 1 tablet MIRAPEXIN 0.088 mg
Croatian: 1 tableta MIRAPEXIN 0,088 mg
English: INFORMATION IN BRAILLE MIRAPEXIN 0.18 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 0,18 mg
English: INFORMATION IN BRAILLE MIRAPEXIN 0.7 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 0,7 mg
English: INFORMATION IN BRAILLE MIRAPEXIN 1.05 mg prolonged-release tablets
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MIRAPEXIN 1,05 mg tablete s produljenim oslobađanjem
English: In advanced Parkinson's disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of MIRAPEXIN.
Croatian: Tijekom početne titracije MIRAPEXINA kod uznapredovale Parkinsonove bolesti, može doći do pojava diskinezije kod bolesnika liječenih kombinacijom pramipeksola i levodope.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/051/011 [30 tablets]
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/97/051/011 [30 tableta]
English: EU/1/97/051/004 [100 tablets]
Croatian: EU/1/97/051/004 [100 tableta]
English: Each tablet contains 0.5 mg pramipexole dihydrochloride monohydrate equivalent to 0.35 mg pramipexole.
Croatian: Jedna tableta sadrži 0,5 mg pramipeksoldiklorid hidrata, što odgovara 0,35 mg pramipeksola.
English: Each prolonged-release tablet contains 2.25 mg pramipexole dihydrochloride monohydrate equivalent to 1.57 mg pramipexole.
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 2,25 mg pramipeksoldiklorid hidrata što odgovara 1,57 mg pramipeksola.